beta
Trial Radar AI
Clinical Trial NCT07147608 (SAPHIR2) for General Population (no Specific Condition or Disease) is recruiting. See the Trial Radar Card View and AI discovery tools for all the details. Or ask anything here.
One study matched filter criteria
Card View
Back to Search

SAPHIR2 : Simplification of PHysical Activity Assessment by Rapid Interrogation 118

Recruiting
Clinical Trial NCT07147608 (SAPHIR2) is an observational study for General Population (no Specific Condition or Disease) that is recruiting. It started on 19 December 2025 with plans to enroll 118 participants. Led by University Hospital, Angers, it is expected to complete by 1 June 2027. The latest data from ClinicalTrials.gov was last updated on 29 December 2025.
Brief Summary
A multicentric, non-interventional study using a clinical questionnaire (SAPHIR) and activity monitor (Activ-PAL) to estimate the level of physical activity in the general population.

This study compares the level of physical activity reported by the SAPHIR questionnaire with the activity recorded by the activity monitor during the same period, in order to determine if the SAPHIR score is able to represent the measu...

Show More
Detailed Description
Promotion of physical activity has been an important public health issue in France for around ten years, as demonstrated by numerous reports and public health plans 'qui ont vu le jour" with this aim. (Plan national nutrition santé PNNS 2011-2015 ; Plan obésité PO 2010-2013 ; Plan cancer 2014-2019). In order to continue promoting physical activity (PA), it is necessary to have a well-adapted, simple and rapid tool is...Show More
Official Title

Simplification of PHysical Activity Assessment by Rapid Interrogation - Phase 2

Conditions
General Population (no Specific Condition or Disease)
Publications
Scientific articles and research papers published about this clinical trial:
Other Study IDs
  • SAPHIR2
  • 49RC25_0220
NCT ID Number
NCT07147608
Start Date (Actual)
2025-12-19
Last Update Posted
2025-12-29
Completion Date (Estimated)
2027-06
Enrollment (Estimated)
118
Study Type
Observational
Status
Recruiting
Keywords
exercise
sedentary behavior
sports medicine
Arms / Interventions
Participant Group/ArmIntervention/Treatment
SAPHIR2 cohort
Initial physical activity questionnaire, wearing the actimeter for 7 days, final physical activity questionnaire
actimeter wearing
actimeter wearing during 7 days : recording of physical activity over 7 days using a non-invasive external sensor
physical activities questionnaires
IPAQ and SAPHIR questionnaires
Primary Outcome Measures
Outcome MeasureMeasure DescriptionTime Frame
correlation between SAPHIR score completed at inclusion and the level of physical activity estimated from measurement data collected using the Activ-PAL® activity monitor
A score is based on the time spent at each intensity level of physical activity, using the correlation between cadence and METs extrapolated from the literature (Tudor-Locke et al, 2020). The primary outcome measure is the correlation coefficient between the amount of physical activity estimated by the SAPHIR score and that estimated from the Activ-PAL data.
7 days
Secondary Outcome Measures
Outcome MeasureMeasure DescriptionTime Frame
correlation between the final SAPHIR score (completed at the end of the measurement week) and the amount of physical activity calculated from the Activ-PAL® activity monitor data
The first secondary outcome measure is the correlation coefficient between the SAPHIR score and the amount of activity estimated from Activ-PAL® data.
7 days
correlation between the initial SAPHIR score and the IPAQ score (baseline)
The second secondary outcome measure is the correlation coefficient between the initial SAPHIR score and the initial IPAQ score
inclusion
correlation between the final SAPHIR score and the final IPAQ score
The third secondary outcome measure is the correlation coefficient between the final SAPHIR score and the final IPAQ score
7 days
correlation between the initial IPAQ score (at the beginning of the week) and the amount of physical activity calculated using Activ-PAL® data i
The fourth secondary outcome measure is the correlation coefficient between the initial IPAQ score and the amount of physical activity estimated from Activ-PAL® data, using the method described for the primary outcome
7 days
correlation between the final IPAQ score (at the end of the recording week) and the amount of physical activity calculated using Activ-PAL® data
The fifth secondary outcome measure is the correlation coefficient between the final IPAQ score and the amount of activity measured from Activ-PAL® data, following the method described for the primary outcome
7 days
Participation Assistant
Eligibility Criteria

Eligible Ages
Adult, Older Adult
Minimum Age
18 Years
Eligible Sexes
All
  • Patients referred for a consultation at one of the participating centers
  • Patients over 18 years old with no upper age limit

Non-inclusion criteria:

  • Patients with a contra-indication to walking
  • Professional athletes or patients participating in endurance sports competitions
  • Patients refusing to participate in the study
  • Patients unable to understand the objectives or instructions of the study

-Patients with Activ-PAL recordings of less than 3 days
University Hospital, Angers logoUniversity Hospital, Angers
Study Central Contact
Contact: Simon LECOQ, MD, 02 41 35 36 37, [email protected]
Contact: Anthéa LOIEZ, 02 41 35 36 37, [email protected]
3 Study Locations in 1 Countries
CHU d'Angers, Angers, 49933, France
Simon LECOQ, MD, Contact, 0241353637, [email protected]
Recruiting
CH de Cholet, Cholet, 49325, France
Jean-Eudes TRIHAN, MD, Contact, 02 41 49 64 30, [email protected]
Not yet recruiting
CH du Mans, Le Mans, 72037, France
Muriel MECHENIN, MD, Contact, 02 43 43 43 43, [email protected]
Not yet recruiting